Sophia Genetics is a health technology company which develops SOPHiA artificial intelligence for clinical genomics used by healthcare institutions worldwide. The Company offers DRY LAB, an analytical solution for treating raw next-generation DNA sequencing (NGS) data; BUNDLE that offers enrichment kit and access to SOPHiA DDM platform; and integrated diagnostic solutions. It also provides SOPHiA DDM, a software-as-a-service platform that enables analysis and protection of clinical NGS data in the areas of oncology, metabolism, pediatrics, cardiology, and hereditary cancer.
Latest funding size
Time since last funding
|9 months ago|
|360 Capital Partners, Invoke Capital Partners, Marc Coucke, Balderton Capital, Alychlo|